Kepler Capital
Kepler Capital is a venture capital firm based in Calgary, Canada. This profile covers what we know about Kepler Capital and how founders can get in front of it in 2026.
Kepler Capital is a private equity firm that focuses on acquiring exceptional small businesses throughout North America.
- Location
- Calgary, Canada
- Team size
- 1-10
How to pitch Kepler Capital
The founders who hear back from Kepler Capital lead with traction and a clear ask that matches its stage, not a generic mass email. Build a targeted, verified list, write a personalized note, and track who opens it, all in one place.
Connect with Kepler Capital
About this profile
This profile is part of Round Funded, an investor database and outreach platform for founders. It covers 60,000+ active VCs, angels, family offices and accelerators with verified contacts, lets you send pitches from your own Gmail, and includes a free Data Room for your raise. How this data is built.
Cite this page
Round Funded. "Kepler Capital." Round Funded investor database, updated October 19, 2026.
Stable URL, it will not change: https://www.roundfunded.com/en/vc/kepler-capital
Frequently Asked Questions
What is Kepler Capital?
Kepler Capital is a venture capital firm based in Calgary, Canada. Round Funded tracks its focus, stage, and activity alongside thousands of active investors.
Where is Kepler Capital based?
Kepler Capital is based in Calgary, Canada. You can reach out from anywhere with a pitch that matches its focus.
How do I contact Kepler Capital?
Unlock a verified email for Kepler Capital and reach out with a personalized pitch on Round Funded. We show only deliverable contacts, so your outreach does not bounce.
What is Round Funded?
Round Funded is an investor database and outreach platform for startup founders. It lists 60,000+ active investors with verified contacts, filtered to recent investment activity, and lets founders send personalized pitches from their own Gmail, track replies, and share a free Data Room. Round+ starts at $99 per month with a 3-day trial.